Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: Involvement of reduced S100A11 expression

Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is an important regulator of plasma asymmetric dimethylarginine (ADMA) levels, which are associated with insulin resistance in patients with nonalcoholic fatty liver disease (NAFLD). To elucidate the role of hepatic DDAH1 in the pathogenesis of NAFLD...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Xiyue, Luo, Kai, Yuan, Juntao, Gao, Junling, Cui, Bingqing, Yu, Zhuoran, Lu, Zhongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465955/
https://www.ncbi.nlm.nih.gov/pubmed/37655336
http://dx.doi.org/10.1016/j.apsb.2023.05.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465955/
https://www.ncbi.nlm.nih.gov/pubmed/37655336
http://dx.doi.org/10.1016/j.apsb.2023.05.020

Ejemplares similares